Pancreatic Cancer Research

ResearcherUniversity of SurreyActive in the last 2 years

Eirini G. Velliou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3313-4446; OpenAlex author ID A5076571268. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 11)
Trials
0
Grants
0
Labs led
2
Collaborators
27
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 4 papers · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers

Papers 18

  1. Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion. Last author DOI 10.1016/j.bioadv.2026.214984↗
  2. Correction to "Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer". Last author DOI 10.1021/acsami.6c14723↗
  3. Single-Cell Lipidomics by LC-MS Interlaboratory Study Reveals the Impact of X-ray Irradiation on a Pancreatic Cancer Cell Line and Its Bystanders. Co-author DOI 10.1021/acs.analchem.5c02010↗
  4. Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer. Last author DOI 10.1021/acsami.5c02296↗
  5. Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenviro… Last author DOI 10.1002/adbi.202300580↗
  6. The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Co-author DOI 10.1097/js9.0000000000001762↗
  7. A Step-by-Step Methodological Guide for Developing Zonal Multicellular Scaffold-Based Pancreatic Cancer Models. First author DOI 10.1007/978-1-0716-3056-3_13↗
  8. Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.analchem.3c02854↗
  9. Enhanced effect of X-rays in the presence of a static magnetic field within a 3D pancreatic cancer model. Co-author DOI 10.1259/bjr.20220832↗
  10. Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study. Co-author DOI 10.3390/ijms242316888↗
  11. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. Last author DOI 10.1259/bjr.20201397↗
  12. Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer. Co-author DOI 10.3390/cancers13122940↗
  13. On the Evaluation of a Novel Hypoxic 3D Pancreatic Cancer Model as a Tool for Radiotherapy Treatment Screening. Last author DOI 10.3390/cancers13236080↗
  14. A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment. Last author DOI 10.3389/fbioe.2020.00290↗
  15. Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. Last author DOI 10.1039/c9ra09123h↗
  16. Biophysical interactions between pancreatic cancer cells and pristine carbon nanotube substrates: Potential application for pancreatic cancer tissue engineerin… Last author DOI 10.1002/jbm.b.34012↗
  17. A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma. Last author DOI 10.1039/c8ra02633e↗
  18. Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer. Last author DOI 10.1016/j.drudis.2017.01.012↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Priyanka Gupta · 12 shared papers, 2019–2026 · strength 2.73
  2. Pedro Antonio Pérez-Mancera · 7 shared papers, 2017–2026 · strength 1.47
  3. Hemant Mahendrakumar Kocher · 5 shared papers, 2020–2026 · strength 1.30
  4. Giuseppe Schettino · 7 shared papers, 2019–2025 · strength 1.23
  5. Gabrielle Wishart · 4 shared papers, 2021–2023 · strength 0.75
  6. Anna-Dimitra Kataki · 2 shared papers, 2025–2026 · strength 0.58
  7. Yaohe Wang · 2 shared papers, 2025–2026 · strength 0.58
  8. Melanie Jane Bailey · 2 shared papers, 2023–2025 · strength 0.44
  9. Kyle D. G. Saunders · 2 shared papers, 2023–2025 · strength 0.44
  10. Stella Totti · 4 shared papers, 2017–2019 · strength 0.35
  11. Nabeel Merali · 2 shared papers, 2023–2024 · strength 0.31
  12. Nicola E. Annels · 2 shared papers, 2023–2024 · strength 0.31
  13. Tarak Agrebi Moumni Chouari · 2 shared papers, 2023–2024 · strength 0.31
  14. Keith John Roberts · 2 shared papers, 2023–2024 · strength 0.31
  15. Elisa Giovannetti · 2 shared papers, 2023–2024 · strength 0.31
  16. Adam Enver Frampton · 2 shared papers, 2023–2024 · strength 0.31
  17. Shivan Sivakumar · 2 shared papers, 2023–2024 · strength 0.31
  18. Camino Bermejo‐Rodríguez · 1 shared paper, 2024 · strength 0.28
  19. James Michael Halle-Smith · 1 shared paper, 2024 · strength 0.17
  20. Dongmei Deng · 1 shared paper, 2024 · strength 0.17
  21. Daniel Liu · 1 shared paper, 2023 · strength 0.14
  22. Jonathan Krell · 1 shared paper, 2023 · strength 0.14
  23. Brigitta Matta‐Domjan · 1 shared paper, 2018 · strength 0.07
  24. Daniel H. Palmer · 1 shared paper, 2017 · strength 0.07
  25. John P. Neoptolemos · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.